Opinion

Video

Challenges of PSA as a Diagnostic Biomarker

The key opinion leaders explore the challenges and limitations associated with using prostate-specific antigen (PSA) as a biomarker for prostate cancer detection and monitoring.

Video content above is prompted by the following question:

  • What are some challenges or limitations in using PSA as a biomarker?
Related Videos
Betty Wang, MD, discusses studies from the 2025 EAU meeting
Dr Louise Kostos answers a question during a Zoom video interview
Dr Louise Kostos answers a question during a Zoom video interview
© 2025 MJH Life Sciences

All rights reserved.